Interestingly, we observed that several anti-PTM antibodies are present and even more prevalent in AIH patients who were ‘sero-negative’ for the classical autoantibodies at diagnosis, compared to patients who were positive for either ANA or SMA. This evidence concerns the gene SMN1 and autoimmune hepatitis.